17:34 , Oct 15, 2018 |  BC Extra  |  Company News

New CEO Forster eyes capital raise for F-star

Immuno-oncology company F-star Biotechnology Ltd. (Cambridge, U.K.) named Eliot Forster as CEO, replacing John Haurum. Forster was CEO of Oxford-based TCR biologics play Immunocore Ltd. (Abingdon, U.K.), which he left in February. Since becoming CEO...
07:00 , Jun 1, 2015 |  BC Week In Review  |  Financial News

i-Optics completes venture financing

i-Optics Corp. , The Hague, the Netherlands   Business: Diagnostic   Date completed: 2015-05-22   Type: Venture financing   Raised: EUR13.7 million ($15.6 million)   Investors: Aescap Venture Management; HBM Partners; De Hoge Dennen; NIBC;...
07:00 , Mar 30, 2015 |  BioCentury  |  Finance

Poland backing innovators

The Polish government is backing the country's first life sciences VC to help build innovative life science companies in a country known for its services-oriented healthcare sector. While the capital and infrastructure are available, one...
08:00 , Jan 19, 2015 |  BC Week In Review  |  Financial News

Orphazyme completes venture financing

Orphazyme ApS , Copenhagen, Denmark   Business: Endocrine/Metabolic   Date completed: 2015-01-09   Type: Venture financing   Raised: EUR20 million ($23.6 million)   Investors: Kurma Partners; Idinvest Partners; Novo A/S ; Sunstone; Aescap Venture Management...
07:00 , Oct 28, 2013 |  BC Week In Review  |  Financial News

F-star Alpha completes venture financing

F-star Alpha Ltd. , Cambridge, U.K.   Business: Cancer   Date completed: 10/23/13   Type: Venture financing   Raised: €9.4 million ($12.9 million)   Investors: Atlas Ventures; Aescap Venture Management; TVM Capital; SR One; MP...
07:00 , May 20, 2013 |  BioCentury  |  Finance

Merck Serono's earnest money

Four years after launching a strategic venture fund, the Merck Serono S.A. unit of Merck KGaA is making a long-term commitment with an infusion of €60 million ($77.8 million). While the fund's focus will remain...
07:00 , Sep 12, 2011 |  BC Week In Review  |  Financial News

Orphazyme completes venture financing

Orphazyme ApS , Copenhagen, Denmark   Business: Endocrine/Metabolic   Date completed: 9/8/11   Type: Venture financing   Raised: €14 million ($19.8 million)   Investors: Aescap Venture Management; Novo A/S; Sunstone  ...
08:00 , Feb 7, 2011 |  BC Week In Review  |  Financial News

to-BBB completes venture financing

to-BBB technologies B.V. , Leiden, the Netherlands   Business: Drug delivery, Cancer, Neurology   Date completed: 2/3/11   Type: Venture financing   Raised: €4 million ($5.4 million)   Investors: Industrial Bank of Taiwan; Jonghoud International;...
07:00 , Apr 12, 2010 |  BC Week In Review  |  Financial News

Biocartis completes venture financing

Biocartis S.A. , Lausanne, Switzerland   Business: Diagnostic   Date completed: 4/8/10   Type: Venture financing   Raised: €30 million ($40.5 million)   Investors: Debiopharm Group; Johnson & Johnson Development Corp.; Aescap Venture Management; Biovest...
07:00 , Mar 29, 2010 |  BC Week In Review  |  Financial News

Aquapharm completes venture financing

Aquapharm Biodiscovery Ltd. , Oban, U.K.   Business: Infectious   Date completed: 3/23/10   Type: Venture financing   Raised: £4.2 million ($6.3 million)   Investors: Aescap Venture Management; Tate & Lyle Ventures; Highlands and Islands...